Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E SHEPPARD

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Journal for Immunotherapy of Cancer|October 9, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)Peter Kar Han Lau, Breon Feran, Lorey Smith, et al.
Microbial Genomics|September 5, 2019
Comparison of long-read sequencing technologies in the hybrid assembly of complex bacterial genomesNicola De Maio, Liam P Shaw, Alasdair Hubbard, et al.
The Journal of Clinical Investigation|January 5, 2012
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in miceKathryn M Kinross, Karen G Montgomery, Margarete Kleinschmidt, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2020
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in <i>Escherichia coli</i>Timothy J Davies, Nicole Stoesser, Anna E Sheppard, et al.
Cancer Discovery|January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysisTiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Characterisation of vaginal <i>Lactobacillus</i> isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiomeJenna Wilson, Aleya Sarah Amir Hamzah, Christine Jordan, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Mbio|March 24, 2016
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Nicole Stoesser, Anna E Sheppard, Louise Pankhurst, et al.
Nature Communications|October 16, 2019
IRF2 is a master regulator of human keratinocyte stem cell fateNicolas Mercado, Gabi Schutzius, Christian Kolter, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Journal for Immunotherapy of Cancer|October 9, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)Peter Kar Han Lau, Breon Feran, Lorey Smith, et al.
Microbial Genomics|September 5, 2019
Comparison of long-read sequencing technologies in the hybrid assembly of complex bacterial genomesNicola De Maio, Liam P Shaw, Alasdair Hubbard, et al.
The Journal of Clinical Investigation|January 5, 2012
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in miceKathryn M Kinross, Karen G Montgomery, Margarete Kleinschmidt, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2020
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in <i>Escherichia coli</i>Timothy J Davies, Nicole Stoesser, Anna E Sheppard, et al.
Cancer Discovery|January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysisTiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Characterisation of vaginal <i>Lactobacillus</i> isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiomeJenna Wilson, Aleya Sarah Amir Hamzah, Christine Jordan, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Mbio|March 24, 2016
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Nicole Stoesser, Anna E Sheppard, Louise Pankhurst, et al.
Nature Communications|October 16, 2019
IRF2 is a master regulator of human keratinocyte stem cell fateNicolas Mercado, Gabi Schutzius, Christian Kolter, et al.
Pageof 28